1887

Abstract

SUMMARY

If interferon is produced by the gut-associated lymphoid tissue of healthy rabbits under normal conditions and is not all bound , it may spill over and be detectable in lymph. We therefore measured antiviral activity in lymph and plasma simultaneously. We found that antiviral activity was consistently measurable in abdominal and thoracic lymph but not in plasma or in the lymph collected from the hind leg duct. The antiviral activity was neither due to lipoproteins, nor immunoglobulins, nor to cell-produced viral inhibitors other than interferons. Extensive characterization of the antiviral activity indicated that the inhibitor is either rabbit interferon gamma or an acid-labile interferon alpha or a mixture; appropriate antisera will be necessary to resolve this uncertainty. The results support the view of the existence of a physiological interferon response.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-65-1-101
1984-01-01
2022-07-01
Loading full text...

Full text loading...

/deliver/fulltext/jgv/65/1/JV0650010101.html?itemId=/content/journal/jgv/10.1099/0022-1317-65-1-101&mimeType=html&fmt=ahah

References

  1. Baron S., Mckerlie L. 1981; Broadly active inhibitor of viruses spontaneously produced by many cell types in culture. Infection and Immunity 32:449–453
    [Google Scholar]
  2. Bocci V. 1981a; Production and role of interferon in physiological conditions. Biological Reviews 56:49–85
    [Google Scholar]
  3. Bocci V. 1981b; Pharmacokinetic studies of interferons. Pharmacology and Therapeutics 13:421–440
    [Google Scholar]
  4. Bocci V. 1982; The physiological interferon response: the sites and the meaning. In Human Lymphokines: Biological Immune Response Modifiers pp 241–255 Edited by Khan A., Hill N. O. New York: Academic Press;
    [Google Scholar]
  5. Bollman J. L., Cain J. C., Grindlay J. H. 1948; Techniques for the collection of lymph from the liver, small intestine or thoracic duct of the rat. Journal of Laboratory and Clinical Medicine 33:1349–1352
    [Google Scholar]
  6. Cesario T., Goldstein A., Lindsey M., Dumars K., Tilles J. 1981; Antiviral activities of amniotic fluid. Proceedings of the Society for Experimental Biology and Medicine 168:403–407
    [Google Scholar]
  7. Destefano E., Friedman R. M., Friedman-Kien A. E., Goedert J. J., Henriksen D., Preble O. T., Sonnabend J. A., Vilcek J. 1982; Acid-labile human leukocyte interferon in homosexual men with Kaposi’s sarcoma and lymphadenopathy. Journal of Infectious Diseases 146:451–455
    [Google Scholar]
  8. Finter N. B. 1969; Dye uptake methods for assessing viral cytopathogenicity and their application to interferon assays. Journal of General Virology 5:419–427
    [Google Scholar]
  9. Fischer D. G., Koren H. S., Rubinstein M. 1982; Spontaneous production of interferon by a subpopulation of human peripheral blood lymphocytes. The 3rd Annual International Symposium on Interferons, Miami, November, 1982
    [Google Scholar]
  10. Gornall A. G., Bardawill C. J., David M. M. 1949; Determination of serum proteins by means of the biuret reaction. Journal of Biological Chemistry 177:751–766
    [Google Scholar]
  11. Grasso G., Muscettola M., Bocci V. 1983; The physiological interferon response. I. Cells attached to intrauterine devices release interferon in vitro. Proceedings of the Society for Experimental Biology and Medicine 173:276–280
    [Google Scholar]
  12. Halonen P. E., Toivanen P., Nikkari T. 1974; Non-specific serum inhibitors of activity of haemagglutinins of rabies and vesicular stomatitis viruses. Journal of General Virology 22:309–318
    [Google Scholar]
  13. Havel R. J., Eder H. A., Bragdon J. H. 1955; The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. Journal of Clinical Investigation 34:1345–1353
    [Google Scholar]
  14. Hovanessian A. G., Rollin P., Riviere Y., Pouillart P., Sureau P., Montagnier L. 1981; Protein kinase in human plasma analogous to that present in control and interferon-treated HeLa cells. Biochemical and Biophysical Research Communications 103:1371–1377
    [Google Scholar]
  15. Hughes T. K., Blalock J. E., McKerlie M. L., Baron S. 1981; Cell-produced viral inhibitor: possible mechanism of action and chemical composition. Interferon and Immunity 32:454–457
    [Google Scholar]
  16. Jakab F., Sugar I., Szabo G. 1980; Cannulation of the cervical thoracic duct in the rat. Lymphology 13:184–185
    [Google Scholar]
  17. Kumar S., Baron S. 1981–82; Non-interferon cellular products capable of virus inhibition. In The Interferon System: a Review to 1982 part 1 pp 395–401 Edited by Baron S., Dianzani F., Stanton G. J. Texas Reports on Biology and Medicine; 41:
    [Google Scholar]
  18. Langford M. P., Weigent D. A., Stanton G. J., Baron S. 1981; Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays. In Interferons part A pp 339–346 Edited by Pestka S. New York: Academic Press;
    [Google Scholar]
  19. Lebon P., Girard S., ThÉpot F., Chany C. 1982; The presence of alpha interferon in human amniotic fluid. Journal of General Virology 59:393–396
    [Google Scholar]
  20. Levin S., Hahn T. 1981; Evaluation of the human interferon system in viral disease. Clinical and Experimental Immunology 46:475–483
    [Google Scholar]
  21. Matthews T. H. J., Lawrence M. K., Nair C. D. G., Tyrrell D. A. J. 1976; Antiviral activity in milk of possible clinical importance. Lancet ii:1387–1389
    [Google Scholar]
  22. Montelaro R. C., Fischinger P. J., Larrick S. B., Dunlop N. M., Ihle J. N., Frank H., Schafer W., Bolognesi D. P. 1979; Further characterization of the oncornavirus inactivating factor in normal mouse serum. Virology 98:20–34
    [Google Scholar]
  23. Schattner A., Merlin G., Levin S., Wallach D., Hahn T., Revel M. 1981; Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases. Lancet ii:497–499
    [Google Scholar]
  24. Seganti L., Grassi M., Mastromarino P., Pana’ A., Superti F., Orsi N. 1983; Activity of human serum lipoproteins on the infectivity of rhabdoviruses. Microbiologica (in press)
    [Google Scholar]
  25. WHO Informal Consultation Report Standardization of Interferons Geneva 14–16 June, 1982, pp 1–25
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-65-1-101
Loading
/content/journal/jgv/10.1099/0022-1317-65-1-101
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error